Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.
Publication
, Journal Article
Granger, CB; Armaganijan, LV
Published in: Circulation
January 3, 2012
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
January 3, 2012
Volume
125
Issue
1
Start / End Page
159 / 164
Location
United States
Related Subject Headings
- Thromboembolism
- Stroke
- Risk Factors
- Randomized Controlled Trials as Topic
- Humans
- Cardiovascular System & Hematology
- Cardiotonic Agents
- Atrial Fibrillation
- Anticoagulants
- Administration, Oral
Citation
APA
Chicago
ICMJE
MLA
NLM
Granger, C. B., & Armaganijan, L. V. (2012). Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism. Circulation, 125(1), 159–164. https://doi.org/10.1161/CIRCULATIONAHA.111.031146
Granger, Christopher B., and Luciana V. Armaganijan. “Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.” Circulation 125, no. 1 (January 3, 2012): 159–64. https://doi.org/10.1161/CIRCULATIONAHA.111.031146.
Granger CB, Armaganijan LV. Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism. Circulation. 2012 Jan 3;125(1):159–64.
Granger, Christopher B., and Luciana V. Armaganijan. “Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.” Circulation, vol. 125, no. 1, Jan. 2012, pp. 159–64. Pubmed, doi:10.1161/CIRCULATIONAHA.111.031146.
Granger CB, Armaganijan LV. Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism. Circulation. 2012 Jan 3;125(1):159–164.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
January 3, 2012
Volume
125
Issue
1
Start / End Page
159 / 164
Location
United States
Related Subject Headings
- Thromboembolism
- Stroke
- Risk Factors
- Randomized Controlled Trials as Topic
- Humans
- Cardiovascular System & Hematology
- Cardiotonic Agents
- Atrial Fibrillation
- Anticoagulants
- Administration, Oral